Skip to main content
. 2019 Nov 16;12:1756286419880664. doi: 10.1177/1756286419880664

Figure 3.

Figure 3.

Comparison of regional structural network changes between BSP patients, HFS patients, and HC at baseline: Representation of significant (FDR corrected, p < 0.05) regional between-group differences in degree (left panel) and clustering (right panel) before (pre) BoNT treatment for (a) BSPpre versus HFSpre; (b) BSPpre versus HC; (c) HFSpre versus HC.

BoNT, botulinum neurotoxin; BSP, blepharospasm; FDR, false discovery rate; HC, healthy controls; HFS, hemifacial spasm.